
|Articles|January 19, 2022
Staying at the top: Empowering Providers with the Multimodal Maestro2
Advertisement
Newsletter
Keep your retina practice on the forefront—subscribe for expert analysis and emerging trends in retinal disease management.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Modern Retina
1
Johnson & Johnson’s TECNIS PureSee EDOF IOL cleared for US market
2
Ophthalmic drug shortages more frequent, longer lasting than average
3
Eichenbaum Acorns: Collaborative retina care with Jeffry D. Gerson, OD, FAAO
4
FDA clears phase I/II trial of SVT-001 cell therapy for familial drusen–associated vision loss
5


































